WallStreetZenWallStreetZen

NASDAQ: IKNA
Ikena Oncology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IKNA past revenue growth

How has IKNA's revenue growth performed historically?
Company
-41.35%
Industry
79.55%
Market
15.27%
IKNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IKNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IKNA earnings and revenue history

Current Revenue
$9.2M
Current Earnings
-$68.2M
Current Profit Margin
-744.2%

IKNA Return on Equity

Current Company
-44.2%
Current Industry
-63.5%
Current Market
188%
IKNA's Return on Equity (-44.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IKNA announces earnings.

IKNA Return on Assets

Current Company
-37.3%
Current Industry
2.9%
IKNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IKNA Return on Capital Employed

Current Company
-38.41%
Current Industry
19.5%
IKNA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IKNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IKNA$9.16M-$65.59M-$68.17M-9.66%N/A
CSBR$49.22M-$7.67M-$9.73M+15.19%N/A
MNOV$1.00M-$8.35M-$8.57M-50.23%N/A
MURA$0.00-$192.72M-$207.45MN/AN/A
AEON$0.00$24.09M$24.05MN/AN/A
View Top Biotech Stocks

IKNA earnings dates

Next earnings date
Jun 7, 2024

Ikena Oncology Earnings & Revenue FAQ

What were IKNA's earnings last quarter?

On Invalid Date, Ikena Oncology (NASDAQ: IKNA) reported Q4 2023 earnings per share (EPS) of -$0.40, up 2.56% year over year. Total Ikena Oncology earnings for the quarter were -$19.49 million. In the same quarter last year, Ikena Oncology's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Ikena Oncology stock.

What was IKNA's earnings growth in the past year?

As of Q2 2024, Ikena Oncology's earnings has grown year over year. Ikena Oncology's earnings in the past year totalled -$68.17 million.

What is IKNA's earnings date?

Ikena Oncology's earnings date is Invalid Date. Add IKNA to your watchlist to be reminded of IKNA's next earnings announcement.

What was IKNA's revenue last quarter?

On Invalid Date, Ikena Oncology (NASDAQ: IKNA) reported Q4 2023 revenue of $659.00 thousand up 87.91% year over year. In the same quarter last year, Ikena Oncology's revenue was $5.45 million.

What was IKNA's revenue growth in the past year?

As of Q2 2024, Ikena Oncology's revenue has grown -41.35% year over year. This is 120.9 percentage points lower than the US Biotechnology industry revenue growth rate of 79.55%. Ikena Oncology's revenue in the past year totalled $9.16 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.